Concepedia

Wang Zy

WZ

Statistics

Publications

9

Citations

222

H-Index

9

Active since

1992

Affiliations

Shanghai Institute of Hematology(Current)

Wang Zy is an author at Shanghai Institute of Hematology specializing in medicine, pharmacotherapy, and radiation oncology.

Top concepts

Publications per year

1992–2020

9

Publications

9

Molecular rearrangements of the MYL gene in acute promyelocytic leukemia (APL, M3) define a breakpoint cluster region as well as some molecular variants.

JH Tong, Suwei Dong, Geng Jp et al. · PubMed · 1992 · 53 citations

miR-144-3p serves as a tumor suppressor by targeting FZD7 and predicts the prognosis of human glioblastoma.

Cheng Zx, Song Yx, Wang Zy et al. · PubMed · 2017 · 43 citations

Butorphanol attenuates myocardial ischemia reperfusion injury through inhibiting mitochondria-mediated apoptosis in mice.

Huang Lh, Li J, Gu Jp et al. · PubMed · 2018 · 28 citations

LncRNA PVT1 aggravates the progression of glioma via downregulating UPF1.

Lv Zh, Wang Zy, Li Zy · PubMed · 2019 · 25 citations

Problems existing in differentiation therapy of acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA).

Wang Zy, Z Chen, Wei‐Cheng Huang et al. · PubMed · 1993 · 19 citations

, , +14

1–5 of 9